NAS
ABBV icon

Nicolet Advisory Services’s AbbVie ABBV Stock Holding History

Nicolet Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.39M Sell
10,869
-416
-4% -$94.8K 0.16% 77
2025
Q3 		$2.63M Sell
11,285
-167
-1% -$34K 0.2% 64
2025
Q2 		$2.24M Sell
11,452
-118
-1% -$21.9K 0.19% 68
2025
Q1 		$2.02M Buy
11,570
+84
+0.7% +$16.3K 0.2% 63
2024
Q4 		$2.01M Buy
11,486
+264
+2% +$48.5K 0.18% 65
2024
Q3 		$2.19M Sell
11,222
-129
-1% -$24.1K 0.21% 56
2024
Q2 		$1.91M Buy
11,351
+251
+2% +$41.6K 0.18% 63
2024
Q1 		$1.89M Buy
11,100
+1,212
+12% +$209K 0.19% 61
2023
Q4 		$1.6M Sell
9,888
-13
-0.1% -$1.9K 0.17% 68
2023
Q3 		$1.46M Buy
9,901
+737
+8% +$108K 0.16% 71
2023
Q2 		$1.26M Buy
9,164
+411
+5% +$60.3K 0.14% 79
2023
Q1 		$1.41M Buy
8,753
+488
+6% +$74.6K 0.16% 71
2022
Q4 		$1.3M Buy
8,265
+3,031
+58% +$465K 0.17% 64
2022
Q3 		$724K Sell
5,234
-3
-0.1% -$430 0.12% 72
2022
Q2 		$796K Buy
5,237
+126
+2% +$19.3K 0.12% 76
2022
Q1 		$894K Buy
5,111
+70
+1% +$10.2K 0.12% 73
2021
Q4 		$683K Sell
5,041
-2,731
-35% -$323K 0.08% 86
2021
Q3 		$840K Buy
7,772
+1,528
+24% +$175K 0.11% 79
2021
Q2 		$703K Sell
6,244
-484
-7% -$54.5K 0.09% 84
2021
Q1 		$728K Sell
6,728
-237
-3% -$25.4K 0.1% 75
2020
Q4 		$746K Buy
6,965
+708
+11% +$68K 0.1% 74
2020
Q3 		$548K Sell
6,257
-1,785
-22% -$168K 0.09% 89
2020
Q2 		$790K Buy
8,042
+293
+4% +$25.8K 0.12% 84
2020
Q1 		$590K Buy
7,749
+2,021
+35% +$172K 0.1% 96
2019
Q4 		$507K Sell
5,728
-373
-6% -$31K 0.08% 98
2019
Q3 		$462K Buy
6,101
+930
+18% +$63.8K 0.07% 101
2019
Q2 		$376K Buy
5,171
+14
+0.3% +$1.1K 0.06% 106
2019
Q1 		$416K Buy
+5,157
New +$422K 0.07% 92

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nicolet Advisory Services's ABBV Position: Q4 2025 in Review

Nicolet Advisory Services reduced its AbbVie (ABBV) stake by 3.7% in Q4 2025, selling an estimated $94.8K and leaving 10,869 shares worth $2.39M. The position accounts for 0.16% of the portfolio, ranked #77.

Nicolet Advisory Services first reported a position in ABBV in Q1 2019 and has held it in 28 quarters since. The position peaked at $2.63M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Nicolet Advisory Services held 10,869 shares of AbbVie worth $2.39M as of Q4 2025.
  • Nicolet Advisory Services sold 416 AbbVie shares in Q4 2025, an estimated $94.8K.
  • AbbVie made up 0.16% of Nicolet Advisory Services's portfolio in Q4 2025, its #77 holding.
  • Nicolet Advisory Services first reported a position in AbbVie in Q1 2019 and has held it in 28 quarters since.
  • Nicolet Advisory Services's AbbVie position peaked at $2.63M in Q3 2025.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.